Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0101 Transporter Info
Gene Name	SLC16A10
Transporter Name	Monocarboxylate transporter 10
Gene ID	117247
UniProt ID	Q8TF71

Post-Translational Modification of This DT
Overview of SLC16A10 Modification Sites with Functional and Structural Information
Sequence	M V L S Q E E P D S A R G T S E A Q P L G P A P T G A A P P P G P G P S D S P E A A V E K V E V E L A G P A T A E P H E P P E P P E G G W G W L V M L A A M W C N G S V F G I Q N A C G V L F V S M L E T F G S K D D D K M V F K T A W V G S L S M G M I F F C C P I V S V F T D L F G C R K T A V V G A A V G F V G L M S S S F V S S I E P L Y L T Y G I I F A C G C S F A Y Q P S L V I L G H Y F K K R L G L V N G I V T A G S S V F T I L L P L L L R V L I D S V G L F Y T L R V L C I F M F V L F L A G F T Y R P L A T S T K D K E S G G S G S S L F S R K K F S P P K K I F N F A I F K V T A Y A V W A V G I P L A L F G Y F V P Y V H L M K H V N E R F Q D E K N K E V V L M C I G V T S G V G R L L F G R I A D Y V P G V K K V Y L Q V L S F F F I G L M S M M I P L C S I F G A L I A V C L I M G L F D G C F I S I M A P I A F E L V G A Q D V S Q A I G F L L G F M S I P M T V G P P I A G L L R D K L G S Y D V A F Y L A G V P P L I G G A V L C F I P W I H S K K Q R E I S K T T G K E K M E K M L E N Q N S L L S S S S G M F K K E S D S I I
PTM type	X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation
Serine	17 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A10			[1]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	4
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 4 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A10			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	36
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 36 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC16A10			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	38
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 38 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC16A10			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	97
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 97 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC16A10			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	257
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 257 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC16A10			[1] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	263
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 263 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC16A10			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	266
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 266 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC16A10			[6] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	268
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 268 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC16A10			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	269
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 269 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC16A10			[1] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	272
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 272 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC16A10			[9] , [10]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	498
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 498 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC16A10			[9] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	501
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 501 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC16A10			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	502
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 502 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC16A10			[6] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	503
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 503 has the potential to affect its expression or activity.
PTM Phenomenon 15	Have the potential to influence SLC16A10			[6] , [12]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	504
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 504 has the potential to affect its expression or activity.
PTM Phenomenon 16	Have the potential to influence SLC16A10			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	511
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 511 has the potential to affect its expression or activity.
PTM Phenomenon 17	Have the potential to influence SLC16A10			[13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	513
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Serine 513 has the potential to affect its expression or activity.
Threonine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A10			[14]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	233
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Threonine 233 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A10			[6]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	258
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A10 Threonine 258 has the potential to affect its expression or activity.
Ubiquitination
Lysine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A10			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	508
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A10 Lysine 508 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A10			[16]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	509
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A10 Lysine 509 has the potential to affect its expression or activity.
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A10			[15] , [16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	268
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A10 Serine 268 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A10			[16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	269
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC16A10 Serine 269 has the potential to affect its expression or activity.

References
1	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
2	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
3	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
4	Improved Method for Determining Absolute Phosphorylation Stoichiometry Using Bayesian Statistics and Isobaric Labeling. J Proteome Res. 2017 Nov 3;16(11):4217-4226.
5	Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
6	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
7	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
8	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
9	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
10	Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020 Dec 17;80(6):1104-1122.e9.
11	Integrated Proteomics Reveals Apoptosis-related Mechanisms Associated with Placental Malaria. Mol Cell Proteomics. 2019 Feb;18(2):182-199.
12	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
13	Defeating Major Contaminants in Fe3+- Immobilized Metal Ion Affinity Chromatography (IMAC) Phosphopeptide Enrichment. Mol Cell Proteomics. 2018 May;17(5):1028-1034.
14	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
15	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
16	Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence